Pinter A - Search Results

1

The influence of affinity, efficacy, and slope factor on the estimates obtained by the receptorial responsiveness method (RRM): a computer simulation study.

Grenczer M, Pinter A, Zsuga J, Kemeny-Beke A, Juhasz B, Szodoray P, Tosaki A, Gesztelyi R. Grenczer M, et al. Among authors: pinter a. Can J Physiol Pharmacol. 2010 Nov;88(11):1061-73. doi: 10.1139/y10-078. Can J Physiol Pharmacol. 2010. PMID: 21076494

2

Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.

Grenczer M, Zsuga J, Majoros L, Pinter A, Kemeny-Beke A, Juhasz B, Tosaki A, Gesztelyi R. Grenczer M, et al. Among authors: pinter a. Can J Physiol Pharmacol. 2010 Nov;88(11):1074-83. doi: 10.1139/y10-089. Can J Physiol Pharmacol. 2010. PMID: 21076495

3

Accuracy and Precision of the Receptorial Responsiveness Method (RRM) in the Quantification of A₁ Adenosine Receptor Agonists.

Szabo AM, Viczjan G, Erdei T, Simon I, Kiss R, Szentmiklosi AJ, Juhasz B, Papp C, Zsuga J, Pinter A, Szilvassy Z, Gesztelyi R. Szabo AM, et al. Among authors: pinter a. Int J Mol Sci. 2019 Dec 12;20(24):6264. doi: 10.3390/ijms20246264. Int J Mol Sci. 2019. PMID: 31842299 Free PMC article.

4

Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.

Zsuga J, Erdei T, Szabó K, Lampe N, Papp C, Pinter A, Szentmiklosi AJ, Juhasz B, Szilvássy Z, Gesztelyi R. Zsuga J, et al. Among authors: pinter a. Molecules. 2017 May 19;22(5):839. doi: 10.3390/molecules22050839. Molecules. 2017. PMID: 28534854 Free PMC article.

5

FSCPX, a Chemical Widely Used as an Irreversible A₁ Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.

Erdei T, Szabo AM, Lampe N, Szabo K, Kiss R, Zsuga J, Papp C, Pinter A, Szentmiklosi AJ, Szilvassy Z, Juhasz B, Gesztelyi R. Erdei T, et al. Among authors: pinter a. Molecules. 2018 Aug 30;23(9):2186. doi: 10.3390/molecules23092186. Molecules. 2018. PMID: 30200192 Free PMC article.

6

An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A₁ Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium.

Szabo AM, Erdei T, Viczjan G, Kiss R, Zsuga J, Papp C, Pinter A, Juhasz B, Szilvassy Z, Gesztelyi R. Szabo AM, et al. Among authors: pinter a. Molecules. 2019 Jun 12;24(12):2207. doi: 10.3390/molecules24122207. Molecules. 2019. PMID: 31212849 Free PMC article.

7

Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study.

Pinter A, Soliman AM, Pivneva I, Ghanbariamin R, Yang M, Truong B, Puig L, Lebwohl M. Pinter A, et al. Dermatol Ther (Heidelb). 2024 May 10. doi: 10.1007/s13555-024-01164-6. Online ahead of print. Dermatol Ther (Heidelb). 2024. PMID: 38727996

8

Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.

Paller AS, Pinter A, Wine Lee L, Aschoff R, Zdybski J, Schnopp C, Praestgaard A, Bansal A, Shumel B, Prescilla R, Bastian M. Paller AS, et al. Among authors: pinter a. Adv Ther. 2024 May 2. doi: 10.1007/s12325-024-02866-1. Online ahead of print. Adv Ther. 2024. PMID: 38698171 No abstract available.

9

Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative.

Verbinnen I, Monte-Boquet E, Parow D, Lacombe F, Pothecary A, van Kuijk AWR, Harrington L, Müllerová E, Pinter A, Erstling U, Tomasini A, Helliwell PS. Verbinnen I, et al. Among authors: pinter a. Rheumatol Ther. 2024 Apr 25. doi: 10.1007/s40744-024-00664-3. Online ahead of print. Rheumatol Ther. 2024. PMID: 38662145 Free article.

10

Obesity is linked to disease severity in moderate to severe atopic dermatitis-Data from the prospective observational TREATgermany registry.

Traidl S, Hollstein MM, Kroeger N, Fischer S, Heratizadeh A, Heinrich L, Kind B, Siegels D, Abraham S, Schäfer T, Augustin M, Harder I, Pinter A, Schäkel K, Wollenberg A, Ertner K, Ramaker-Brunke J, Bong A, Quist S, Gorriahn-Maiterth H, Schenck F, Sticherling M, Effendy I, Schwarz B, Handrick C, Asmussen A, Weidinger S, Schmitt J, Werfel T; TREATgermany Study Group. Traidl S, et al. Among authors: pinter a. J Eur Acad Dermatol Venereol. 2024 Apr 25. doi: 10.1111/jdv.20042. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38661511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

664 results

Search Page